Cargando…
Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM)
Introduction Multiple myeloma (MM) patients have an increased risk of severe coronavirus disease 2019 (COVID-19) when infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Monoclonal gammopathy of undetermined significance (MGUS) precedes MM and related disorders and affects 4....
Autores principales: | Rögnvaldsson, Sæmundur, Eythorsson, Elias, Thorsteinsdottir, Sigrun, Vidarsson, Brynjar, Onundarson, Pall Torfi, Agnarsson, Bjarni Agnar, Sigurdardottir, Margret, Thorsteinsdottir, Ingunn, Olafsson, Isleifur, Runolfsdottir, Hrafnhildur Linnet, Helgason, Dadi, Emilsdóttir, Arna, Bjornsson, Aron H, Kristjansdottir, Gudrun, Thordardottir, Asdis Rosa, Indridason, Olafur Skuli, Jonsson, Asbjorn, Gislason, Gauti Kjartan, Olafsson, Andri, Steingrimsdottir, Hlif, Kampanis, Petros, Hultcrantz, Malin, Durie, Brian G.M., Harding, Stephen, Landgren, Ola, Love, Thorvardur Jon, Palsson, Runolfur, Kristinsson, Sigurdur Y |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701832/ http://dx.doi.org/10.1182/blood-2021-153145 |
Ejemplares similares
-
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study
por: Long, Thorir Einarsson, et al.
Publicado: (2022) -
Monoclonal gammopathy of undetermined significance and COVID-19: a population-based cohort study
por: Rognvaldsson, Saemundur, et al.
Publicado: (2021) -
Sars-Cov-2 Vaccinations Do Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study
por: Palmason, Robert, et al.
Publicado: (2022) -
Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2021) -
Correction: Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies
por: Rögnvaldsson, Sæmundur, et al.
Publicado: (2023)